worth buying?, page-4

This is a sleeper until announcements come out then it rockets as its tightly held.

The potential is huge and with Masters and co. involved and theyre ability to keep getting funding its a good bet they are on to something.

If trials continue to be a success with PBT2 next year and they actually develop a successful drug to combat alzheimers then the current prices are ridiculuos compared to what it will be worth in a couple of years.

If you like the story & potential, this is a share to accumulate and put in the bottom drawer. Further info on their website.